Toronto, May 3, 2018 - GMP Capital Inc. (GMP) (TSX: GMP) today reported revenue of $52.5 million in first quarter 2018, up 8% compared with the same period a year ago. First quarter 2018 net income was $4.1 million and EPS was $0.04, compared with net income of $3.5 million and EPS of $0.03 in first quarter 2017. On an adjusted basis1, first quarter 2018 net income was $7.3 million and EPS was $0.08.
“2018 is off to a good start with meaningful growth in our investment banking businesses and ongoing solid contribution from our industry-leading wealth management franchise. Leading the way in investment banking was significant client engagement from our cannabis and blockchain franchises. An explicit element of our strategic agenda has been to diversify and further strengthen the non-commodities portion of our franchise and, we believe, our results this quarter evidences we are on the right path," said Harris Fricker, President and CEO of GMP.
- Earned net income of $4.1 million and diluted earnings per share of $0.04 in first quarter 2018
- On an adjusted basis1, net income was $7.3 million and diluted earnings per share was $0.08
- Investment banking revenue increased 90% led by meaningful client engagement in cannabis and blockchain
For further information about GMP Capital Inc., our results for first quarter 2018 and the meaning of certain references, this earnings release should be read in conjunction with our unaudited interim condensed consolidated financial statements as at and for the three months ended March 31, 2018 (First Quarter 2018 Financial Statements) and our management's discussion and analysis for the three months ended March 31, 2018 (First Quarter 2018 MD&A), which can be accessed on our website at gmpcapital.com and on SEDAR at sedar.com. Unless otherwise indicated, all dollar amounts are expressed in Canadian dollars and have been taken from our First Quarter 2018 Financial Statements prepared in accordance with International Financial Reporting Standards (IFRS).
First Quarter 2018 vs. First Quarter 2017
1. Considered to be a non-GAAP financial measure. This measure does not have any standardized meaning prescribed by generally accepted accounting principles (GAAP) under IFRS and is therefore unlikely to be comparable to similar measures presented by other issuers. This data should be read in conjunction with the “Non-GAAP Measures” section at the end of this press release and the “Presentation of Financial Information and Non-GAAP Measures” section in the First Quarter 2018 MD&A.
FIRST QUARTER 2018 BUSINESS SEGMENT HIGHLIGHTS
First quarter 2018 vs. First quarter 2017
Revenue of $48.8 million increased 28% primarily due to higher investment banking fees and higher interest revenue in connection with increased stock borrowing and lending activity. Partly offsetting the increase was lower commission revenue and lower net gains from principal transactions.
Expenses of $38.3 million increased 5% largely due to higher employee compensation and benefits, which increased 18%. Higher interest expense compared with first quarter 2017 reflects improved stock borrowing and lending activity. These increases were partly offset by lower selling, general and administrative costs, which decreased 25% largely due to lower transaction-related expenses commensurate with the decline in client trading activity over the same period.
Income before income taxes
- First quarter 2018 and first quarter 2017 revenues include $0.6 million and $7.7 million, respectively, in dividends received in connection with GMP's preferred share investments in Richardson GMP.
- Share of Richardson GMP net income of $0.8 million compared with $0.7 million.
Richardson GMP Highlights
The following information sets forth an overview of the consolidated financial results of Richardson GMP, on a 100% basis; noting, however, that GMP owns an approximate 32% non-controlling interest of Richardson GMP as at March 31, 2018.
• Revenue of $75.3 million representing a 3% decrease largely on lower commission revenue.
• Adjusted EBITDA2 of $11.2 million, decreased 1%.
• Assets under administration of $29.9 billion as at March 31, 2018 was largely unchanged compared with the same period a year ago.
2. Considered to be a non-GAAP financial measure. This data should be read in conjunction with the “Supplemental Information” section at the end of this press release and in the First Quarter 2018 MD&A.
On May 2, 2018, the board of directors of GMP approved a quarterly cash dividend of $0.2257 per Cumulative 5-Year Rate Reset Preferred Share, Series B, and $0.2531 per Cumulative Floating Rate Preferred Shares, Series C, payable on July 3, 2018, to preferred shareholders of record on June 15, 2018.
NORMAL COURSE ISSUER BID RENEWAL
On May 2, 2018, the Board of Directors approved the renewal of GMP's normal course issuer bid, which has been accepted by the TSX (2018 NCIB). The 2018 NCIB will commence on May 5, 2018, and will terminate on May 4, 2019, or until such earlier date on which purchases under the 2018 NCIB have been completed. Under the 2018 NCIB, GMP is authorized to purchase for cancellation up to 5,139,428 Common Shares, representing 10% of the public float on April 20, 2018, by way of normal course purchases effected by GMP Securities L.P. through the facilities of the TSX and any other protected marketplace or alternative trading system in Canada. As of April 20, 2018, GMP had 77,970,142 Common Shares outstanding. Purchases will be made by GMP in accordance with the requirements of the TSX and the price which GMP will pay for any such Common Shares will be the market price of any such Common Shares at the time of acquisition, or such other price as may be permitted by the TSX. For purposes of the TSX rules, a maximum of 34,875 Common Shares may be purchased by GMP on any one day under the bid, except where purchases are made in accordance with the “block purchase exception” of the TSX rules. The daily repurchase limit represents 25% of the average daily trading volume of 139,501 Common Shares for the six-month period ended March 31, 2018, excluding purchases made under the previously approved normal course issuer bid program during that period. Pursuant to a previous notice of intention to conduct a normal course issuer bid, under which GMP sought and received approval from the TSX to purchase up to 5,306,499 Common Shares for the period of April 29, 2017 to April 28, 2018, GMP has purchased, as of April 20, 2018, 3,515,064 Common Shares on the open market at an average weighted purchase cost per share of $2.9507. GMP has renewed the 2018 NCIB program because it believes the purchase of Common Shares may at certain times enhance value to shareholders and is an appropriate use of funds. Shareholders may obtain a copy of the filed notice without charge by contacting GMP's Chief Financial Officer by telephone at (416) 367-8600 or toll-free at 1-888-301-3244 or by email at firstname.lastname@example.org.
A conference call and live audio webcast to discuss GMP’s first quarter 2018 results will be held this morning at 9:00 a.m. (EST). Interested parties are invited to access the quarterly conference call on a listen-only basis by dialing 416-340-2216 or 1-800-377-0758 (toll free) or via live audio webcast at http://gmpcapital.com/Investor-Relations/Quarterly-Information. A recording of the conference call will be available until Thursday, May 10, 2018, by dialing 905-694-9451 or 1-800-408-3053 (toll free) and entering access code 7262368#. The webcast will be archived at http://gmpcapital.com/Investor-Relations/Quarterly-Information.
We use certain measures to assess our financial performance that are not GAAP measures under IFRS. These measures do not have any standardized meaning prescribed by GAAP and are therefore unlikely to be comparable to similar measures presented by other issuers. Non-GAAP measures should not be considered as alternatives to net income or comparable metrics determined in accordance with IFRS as indicators of GMP's performance, liquidity, cash flows and profitability. For further information, refer to the “Presentation of Financial Information and Non-GAAP Measures” section in the First Quarter 2018 MD&A.
The following table provides a reconciliation of GMP’s reported results to its adjusted measures including the composition of the adjusted measures for the periods presented.
1. Considered to be non-GAAP financial measures. These measures do not have any standardized meaning prescribed by GAAP under IFRS and are therefore unlikely to be comparable to similar measures presented by other issuers.
SUPPLEMENTAL INFORMATION - RICHARDSON GMP
The following supplemental information reflects how management of Richardson GMP assesses the financial performance of Richardson GMP.
Richardson GMP's management assesses performance on both a reported and an adjusted basis and considers both bases to be useful in assessing underlying, ongoing business performance. Presenting results on both bases also permits readers to assess the impact of specified items on financial results. Richardson GMP's management uses certain measures to assess the financial performance of Richardson GMP that are not GAAP measures under IFRS. EBITDA and adjusted EBITDA do not have any standardized meaning prescribed by GAAP and are therefore unlikely to be comparable to similar measures presented by other issuers. These Non-GAAP measures should not be considered as alternatives to net income or comparable metrics determined in accordance with IFRS as indicators of Richardson GMP's performance, liquidity, cash flows and profitability. Richardson GMP's management believes adjusting results by excluding the impact of the specified items is more reflective of ongoing financial performance and cash generating capabilities and provides readers with an enhanced understanding of how management views Richardson GMP's core performance. For further information, refer to the "Supplemental Information" section in the First Quarter 2018 MD&A.
The following table sets forth an overview of the consolidated financial results of Richardson GMP for the periods indicated, on a 100% basis; noting, however, that GMP owns an approximate 32% non-controlling interest of Richardson GMP as at March 31, 2018.
1. Considered to be a non-GAAP financial measure. This measure does not have any standardized meaning prescribed by GAAP under IFRS and is therefore unlikely to be comparable to similar measures presented by other issuers.
This press release contains “forward-looking information” as defined under applicable Canadian securities laws. This information includes, but is not limited to, statements concerning our objectives, our strategies to achieve those objectives, as well as statements made with respect to management's beliefs, plans, estimates, projections and intentions, and similar statements concerning anticipated future events, results, circumstances, performance or expectations that are not historical facts. Forward-looking information generally can be identified by the use of forward-looking terminology such as “outlook”, “objective”, “may”, “will”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “should”, “plans” or “continue”, or similar expressions suggesting future outcomes or events. Such forward-looking information reflects management's current beliefs and is based on information currently available to management.
Forward-looking information is not a guarantee of future performance and is subject to numerous risks and uncertainties, including those described in this press release. GMP's primary business activities are both competitive and subject to various risks. These risks include market, credit, liquidity, operational and legal and regulatory risks and other risk factors including, without limitation: variation in the market value of securities, volatility and liquidity of equity and fixed income trading markets, volume of new financings and mergers and acquisitions, dependence on key personnel and sustainability of fees. Other factors, such as general economic conditions, including interest rate and exchange rate fluctuations, may also have an effect on GMP's results of operations. Many of these risks and uncertainties can affect GMP's actual results and could cause its actual results to materially differ from those expressed or implied in any forward-looking information disclosed by management or on its behalf. For a description of additional risks that could cause our actual results to materially differ from our current expectations, see “Risk Management” and "Risk Factors" in the First Quarter 2018 MD&A and “Risk Factors” in GMP's annual information form. These risks and uncertainties are not the only ones facing GMP together with its consolidated operations controlled by it and its predecessors (GMP Group). Additional risks and uncertainties not currently known to us or that we currently consider immaterial may also impair the operations of the GMP Group. Material assumptions or factors underlying the forward-looking information contained in this press release include, but are not limited to, “First Quarter 2018 Financial Highlights”, “Segment Results” and “Liquidity and Capital Resources” sections of the First Quarter 2018 MD&A. Although forward-looking information contained in this press release is based upon what management believes are reasonable assumptions, there can be no assurance that actual results will be consistent with this forward-looking information. Certain statements included in this press release may be considered a “financial outlook” for purposes of applicable Canadian securities laws, and as such the financial outlook may not be appropriate for purposes other than this press release. The forward-looking information contained in this press release is made as of the date of this press release, and should not be relied upon as representing GMP's views as of any date subsequent to the date of this press release. Except as required by applicable law, management and GMP's Board of Directors undertake no obligation to publicly update or revise any forward-looking information, whether as a result of new information, future events or otherwise.
ABOUT GMP CAPITAL INC.
GMP is a leading independent diversified financial services firm headquartered in Toronto, Canada, providing a wide range of financial products and services to a global client base that includes corporate clients, institutional investors and high-net-worth individuals in two integrated reporting segments. The Capital Markets segment provides investment banking, including advisory and underwriting services, institutional sales and trading and research through offices in Canada, the United States, the United Kingdom and the Bahamas. Wealth Management consists of GMP’s non-controlling ownership interest in Richardson GMP Limited. Richardson GMP Limited, Canada’s largest independent wealth management firm, is focused on providing exclusive and comprehensive wealth management and investment services delivered by an experienced team of investment professionals. GMP is listed on the Toronto Stock Exchange under the symbol “GMP”. For further information, please visit our corporate website at gmpcapital.com.
For further information please contact:
GMP Capital Inc.
Rocco Colella, Director, Investor Relations
145 King Street West, Suite 300, Toronto, Ontario M5H 1J8
Tel: (416) 941-0894; Fax: (416) 943-6175
email@example.com or firstname.lastname@example.org